These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3326399)

  • 1. Ascending urinary tract infections in rats induced by Staphylococcus saprophyticus and Proteus mirabilis.
    Hjelm E; Lundell-Etherden I; Mårdh PA
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):347-50. PubMed ID: 3326399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Proteus mirabilis urinary tract infection.
    Coker C; Poore CA; Li X; Mobley HL
    Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis.
    Silverblatt FJ; Ofek I
    J Infect Dis; 1978 Nov; 138(5):664-7. PubMed ID: 361900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swarming and pathogenicity of Proteus mirabilis in the urinary tract.
    Mobley HL; Belas R
    Trends Microbiol; 1995 Jul; 3(7):280-4. PubMed ID: 7551643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple renal abscesses due to Proteus mirabilis.
    Kakuchi Y
    Clin Exp Nephrol; 2021 Mar; 25(3):322-323. PubMed ID: 33070221
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a rat model for induction of pyelonephritis with cell wall deficiency variants of Proteus mirabilis.
    Hughes BF; Schwarz H; Gomolka D
    Invest Urol; 1972 Jul; 10(1):10-3. PubMed ID: 4556712
    [No Abstract]   [Full Text] [Related]  

  • 8. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.
    Pearson MM; Mobley HLT
    J Med Microbiol; 2007 Oct; 56(Pt 10):1277-1283. PubMed ID: 17893161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection.
    Mobley HL; Belas R; Lockatell V; Chippendale G; Trifillis AL; Johnson DE; Warren JW
    Infect Immun; 1996 Dec; 64(12):5332-40. PubMed ID: 8945585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth, cellular differentiation and virulence factor expression by Proteus mirabilis in vitro and in vivo.
    Zunino P; Piccini C; Legnani-Fajardo C
    J Med Microbiol; 1999 Jun; 48(6):527-534. PubMed ID: 10359301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Legnani-Fajardo C; Maskell DJ
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):137-43. PubMed ID: 11024353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental pyelonephritis from Proteus mirabilis L forms in rats].
    Toshkov A; Kuiumdzhiev A; Zakharieva S; Georgiev D; Gumpert I
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():42-8. PubMed ID: 343511
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
    Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
    Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats.
    Gatermann S; John J; Marre R
    Infect Immun; 1989 Jan; 57(1):110-6. PubMed ID: 2909483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinating and adherence properties of Staphylococcus saprophyticus: epidemiology and virulence in experimental urinary tract infection of rats.
    Gatermann S; Marre R; Heesemann J; Henkel W
    FEMS Microbiol Immunol; 1988 Dec; 1(3):179-85. PubMed ID: 3273467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL; Chippendale GR
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteus mirabilis and Urinary Tract Infections.
    Schaffer JN; Pearson MM
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.
    Massad G; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.